Rothera Mark - Insider Non-Derivative Transactions at Viracta Therapeutics, Inc. (VIRX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Dec 1, 2023, Rothera Mark's relationship to Viracta Therapeutics, Inc. (VIRX) is Director,Officer (President and CEO), and currently has 100,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other VIRX insiders.
Data Source: SEC.
Rothera Mark - Insider Non-Derivative Transactions of VIRX Common Stock
Rothera Mark - Insider Non-Derivative Transactions at VIRX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 2, 2023 | P -- (Common Stock) | 47906 | 0.49 | 100000 |
| Dec 1, 2023 | P -- (Common Stock) | 52094 | 0.49 | 52094 |